The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNature Group Regulatory News (NGR)

  • There is currently no data for NGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

23 Sep 2008 07:00

RNS Number : 0117E
Nature Technology Solutions Limited
23 September 2008
 



Nature Technology Solutions Ltd

(the "Company")

Interim 2008 Results

Results

I am pleased to report that the improvement in performance by the Group in 2007 has been maintained, with the achievement of a Group net profit for the six months ended 30th June 2008 of £193,883, compared with £33,339 for the same period in 2007. Attributable turnover in the six months increased to £1,420,872 compared to £967,056 last year. The profit shown includes a one-off currency translation gain of £32,190, which under international accounting standards is correctly included in the Profit and Loss account. Excluding this gain, Group profits for the period still showed an excellent increase over the same period last year.

Whilst revenues from deliveries of equipment, services and technology increased modestly over the same period of 2007, our share of joint-venture revenues from Gibraltar and Norway maintained the growth we had planned for, but Gibraltar revenues may now flatten out in the second half on a comparative basis to last year, due to the 'non-recurring' pollution stand-by contract awarded in the final six months of 2007. 

Other financial aspects

The reduction in net cash as at 30th June 2008 was a consequence of the increased level of turnover leading to higher receivables and the timing of dividend receipts from our joint ventures operations. However, the receipt of dividends in July 2008 onwards has restored the cash position to a level comparable to 2007. It should be noted that substantial cash reserves that may build up in our joint ventures are not consolidated in these accounts unless transferred to joint venture partners by way of internal dividend.

With the contracted deployment in the second quarter of our Offshore Treatment Unit ('OTU'), we have felt it prudent to commence the depreciation of the build and development costs of this unit , although our technology for offshore treatment could still be regarded as in a development phase . However, there is further penetration of the OTU market to achieve, despite our currently successful offshore phase as referenced below.

Treatment Units 

 

As announced in my Chairman's Statement of June 2008 , our 'OTU' was deployed to a drilling rig in Norway at end-April and will remain on that contract to at least mid October. Our discussions with regard to offshore treatment of rig-based fluids waste in Norway are continuing and may lead to further supply contracts for 2009 - either on a rental or outright sale basis. Also at end July, I announced the award to the Group of a contract to supply a modular treatment unit to a major oilfield service group in Kazakhstan for delivery within 2008, and that contract is now under final engineering design and manufacture. 

Gibraltar and Port activities

Our Gibraltar joint venture achieved useful growth once again as highlighted above, and we are actively reviewing business opportunities to further increase its long term revenues and profits. Our Ports-related team is responding to several enquiries for stand-alone treatment plants in a number of locations in the Mediterranean and Middle East.

Other locations

Whilst it is also our plan to secure a suitable commercial entry to a UK North Sea port location such as Aberdeen, and indeed to diversify into related activities in the UK, we have not yet been able to secure such an opportunity on suitable terms.

Share Capital

Under prevailing Stock Market conditions it is not proving possible to achieve the growth in capital value, as expressed by our quoted share price, that we had hoped to deliver to shareholders,even though our results are generating useful net earnings per share. However, we will continue to focus on building valuable environmental treatment businesses within our Group which, if successful, should contribute to progressively increasing the inherent value attributable to shareholders..

In conclusion, shareholders will be aware that in July the consolidation of our share capital was approved and implemented. As a result your Company now has in issue 24,819,669 ordinary shares of 0.2p nominal value per share. All shareholders will have received new share certificates reflecting their consolidated shareholding, being one twentieth in number of those previously held.

Richard Eldridge

Chairman

23 September 2008

For further information:

Nature Technology Solutions Limited

Richard Eldridge, CEO Tel: 0798 940 5181
Peter Snell, Non-Executive Director Tel: 07000 892 481
 
Seymour Pierce Limited
Jonathan Wright, Director Tel: 020 7107 8000

 

 

PROFIT AND LOSS ACCOUNT

FOR THE HALF YEAR TO 30TH JUNE 2008

Unaudited

Unaudited

Audited

Six months to

Six months to

Year to

30/06/2008

30/06/2007

31/12/2007

£

£

£

REVENUE

Subsidiary operations

633,077

531,097

1,030,888

Joint venture

787,795

435,958

1,223,346

 

 

 

1,420,872

967,055

2,254,234

OPERATING COSTS

Subsidiary operations

(324,044)

(260,272)

(517,375)

Joint venture

(441,452)

(235,094)

(616,019)

 

 

 

OPERATING PROFIT 

655,376

471,689

1,120,840

Interest receivable

1,558

528

18,962

Administrative costs

(354,427)

(365,068)

(582,878)

Bank interest and charges

(7,859)

(12,237)

(24,496)

Profit on exchange

32,190

-

23,571

Depreciation and goodwill amortisation

(132,955)

(72,323)

(164,015)

 

 

 

Profit on ordinary activities before taxation

193,883

22,589

391,984

Minority interest

-

10,749

-

Taxation on profit on ordinary activities

-

-

(79,873)

 

 

 

Profit for the financial period

193,883

33,338

312,111

Basic profit per share on shares in issue as at 30th June 2008

0.00039

0.00007

0.00064

 

Basic profit per share on shares currently in issue 

0.0078

  

BALANCE SHEET AT 30TH JUNE 2008

Unaudited

Unaudited

Audited

As at 

As at 

As at

30/06/08

30/06/07

31/12/07

£

£

£

ASSETS:

Non current assets

Plant and equipment

708,408

511,653

678,762

Intangible assets

234,137

148,988

152,172

Investments

2,121,852

1,799,846

1,954,553

Deferred tax asset

58,939

110,888

85,047

 

 

 

Total non current assets

3,123,336

2,571,375

2,870,534

Current assets

Trade and other receivables

506,255

98,999

305,780

Cash and cash equivalents

3,167

556,556

268,375

Total current assets

509,422

655,555

574,155

TOTAL ASSETS

3,632,758

3,226,930

3,444,689

LIABILITIES:

Current liabilities

(283,434)

(322,754)

(323,304)

Non -current liabilities

Long term loan

(240,807)

(287,246)

(227,085)

Minority interest

-

(1,402)

-

 

 

 

NET ASSETS

3,108,517

2,615,528

2,894,300

EQUITY

Called up share capital

49,639

46,859

49,239

Share premium

1,998,570

1,981,016

1,978,636

Capital Reserve

2,864,130

2,864,130

2,864,130

Profit and loss account

(1,803,822)

(2,276,477)

(1,997,705)

 

 

 

Total equity attributable to equity shareholders

3,108,517

2,615,528

2,894,300

  

CASH FLOW STATEMENT

FOR THE HALF YEAR TO 30TH JUNE 2008

Unaudited

Unaudited

Audited

half year to

half year to

year to

30/06/08

30/06/07

31/12/07

£

£

£

Reconciliation of operating profit to net cash flow from operating activities:

Operating profit

193,883

33,338

391,984

Depreciation

132,955

72,323

9,539

(Increase)/Decrease in debtors

(200,475)

106,392

(74,548)

(Decrease)/increase in creditors

(26,148)

89,704

(49,780)

Decrease/(Increase) in minority interests

-

(10,749)

(12,151)

 

 

 

Net cash from operating activities

100,215

291,008

265,044

Investing activities:

Increase in investments

(167,299)

(83,990)

(238,697)

Acquisition of fixed assets

(198,124)

(150,084)

(257,594)

 

Financing activities:

Cash consideration from issuance of shares

-

287,720

287,720

net of issuance costs

 

 

 

Increase/(Decrease) in cash balances

(265,208)

344,654

56,473

Movement in cash balances:

Balance at bank 1st January 2008

268,375

211,902

211,902

Net cash inflow/(outflow)

(265,208)

344,654

56,473

 

 

 

Balance at 30th June 2008

3,167

445,907

268,375

Notes to the accounts:

1. The calculation of profit per share has been based on the profit for the period and the average 492,393,384 Ordinary Shares in issue throughout the period.

2. These unaudited results have been prepared on the basis of the accounting policies adopted in the accounts to 31 December 2007.

3. The interim report to 30 June 2008 was approved by the directors on 22 September 2008. The report  will be posted to shareholders and will be available to the public, free of charge, from the officies of Seymour Pierce Limited, 20 Old Bailey, London EC4M 7EN.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FKBKBPBKDFCB
Date   Source Headline
27th Sep 20184:01 pmRNSCancellation of Trading and Interim Results
1st Aug 20187:00 amRNSResult of AGM
31st Jul 20183:37 pmRNSPosting of Annual Reports & Accounts
27th Jul 20181:08 pmRNSResult of AGM & Update re Annual Report & Accounts
5th Jul 201810:00 amRNSNotice of Annual General Meeting
2nd Jul 201812:40 pmRNSTrading Update
7th Jun 20187:00 amRNSUpdate on Annual Report and Annual General Meeting
1st May 20187:00 amRNSTrading Update
27th Mar 201812:30 pmRNSSuspension - Nature Group plc
27th Mar 201812:30 pmRNSStatement re. Suspension
19th Mar 20182:47 pmRNSHolding(s) in Company
15th Mar 20187:00 amRNSFurther re: Trading Update
7th Mar 20187:00 amRNSTrading Update
17th Nov 201710:56 amRNSStrategic Partner & sale of interest in US
5th Oct 20173:21 pmRNSDirector Loan
29th Sep 20177:07 amRNSInterim Results
9th Aug 20177:00 amRNSDirectorate Change
18th Jul 201710:02 amRNSBoard Changes
30th Jun 201712:07 pmRNSHolding(s) in Company
30th Jun 20178:00 amRNSDirector/PDMR Shareholding
27th Jun 201711:17 amRNSResult of AGM
27th Jun 201710:11 amRNSAGM Statement
15th Jun 20172:37 pmRNSUpdate on Oil & Gas contract
2nd Jun 201710:46 amRNSPosting of Annual Report & Accounts
31st May 20177:00 amRNSFinal Results
18th May 20174:30 pmRNSNotice of Results
21st Apr 20174:18 pmRNSDirector/PDMR Shareholding
13th Apr 20178:00 amRNSTrading Update
24th Mar 20175:49 pmRNSDirector/PDMR Shareholding
6th Feb 20175:23 pmRNSGrant of Options
20th Jan 201712:33 pmRNSHolding(s) in Company
20th Jan 201712:32 pmRNSHolding(s) in Company
18th Jan 20172:38 pmRNSDirector/PDMR Shareholding
17th Jan 20177:00 amRNSSale of Gibraltar Operations
22nd Dec 201612:01 pmRNSSignificant Oil & Gas Contract Win
9th Dec 20161:03 pmRNSBoard Changes
28th Sep 20167:00 amRNSInterim Results
19th Sep 20164:17 pmRNSAcquisition of Interest in NEMS
29th Jun 20164:13 pmRNSResult of AGM
2nd Jun 20167:00 amRNSAnnual Financial Report
27th May 20167:00 amRNSFinal Results
19th May 201611:42 amRNSNotice of Results
4th Apr 20167:00 amRNSDirectorate Change
15th Feb 20168:15 amRNSTrading Statement
20th Jan 20167:00 amRNSNature Environmental & Marine Services LLC Update
2nd Dec 201512:21 pmRNSProposed Sale of Gibraltar Operations
21st Oct 20157:00 amRNSDirectorate Change
22nd Sep 20157:00 amRNSHalf Yearly Report
15th Sep 201510:05 amRNSNotice of Results
13th Aug 201511:49 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.